Evidence map›Paper›PMID 23002355›Full record

ReviewWorld journal of gastroenterology2012

Quality of ulcer healing in gastrointestinal tract: its pathophysiology and clinical relevance.

Tetsuo Arakawa, Toshio Watanabe, Tetsuya Tanigawa, Kazunari Tominaga, Yasuhiro Fujiwara, Ken'ichi Morimoto

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 63 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Network Pharmacology and Molecular Docking Analysis on Pharmacological Mechanisms ofEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  13. Article
  14. Article
  15. Gastroprotective Mechanism and Ulcer Resolution Effect ofEvidence-based complementary and alternative medicine : eCAM · 2018
    Article
  16. Article
  17. Article
  18. Garidisan: Improving the Quality of Ulcer Healing in Rats with Ulcerative Colitis.Evidence-based complementary and alternative medicine : eCAM · 2017
    Article
  19. Review
  20. Potential role of probiotics in the management of gastric ulcer.Experimental and therapeutic medicine · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tetsuo ArakawaDepartment of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan. arakawat@med.osaka-cu.ac.jp
Toshio Watanabe
Tetsuya Tanigawa
Kazunari Tominaga
Yasuhiro Fujiwara
Ken'ichi Morimoto
Osaka City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this paper, we review the concept of quality of ulcer healing (QOUH) in the gastrointestinal tract and its role in the ulcer recurrence. In the past, peptic ulcer disease (PUD) has been a chronic disease with a cycle of repeated healing/remission and recurrence. The main etiological factor of PUD is Helicobacter pylori (H. pylori), which is also the cause of ulcer recurrence. However, H. pylori-negative ulcers are present in 12%-20% of patients; they also recur and are on occasion intractable. QOUH focuses on the fact that mucosal and submucosal structures within ulcer scars are incompletely regenerated. Within the scars of healed ulcers, regenerated tissue is immature and with distorted architecture, suggesting poor QOUH. The abnormalities in mucosal regeneration can be the basis for ulcer recurrence. Our studies have shown that persistence of macrophages in the regenerated area plays a key role in ulcer recurrence. Our studies in a rat model of ulcer recurrence have indicated that proinflammatory cytokines trigger activation of macrophages, which in turn produce increased amounts of cytokines and chemokines, which attract neutrophils to the regenerated area. Neutrophils release proteolytic enzymes that destroy the tissue, resulting in ulcer recurrence. Another important factor in poor QOUH can be deficiency of endogenous prostaglandins and a deficiency and/or an imbalance of endogenous growth factors. Topically active mucosal protective and antiulcer drugs promote high QOUH and reduce inflammatory cell infiltration in the ulcer scar. In addition to PUD, the concept of QOUH is likely applicable to inflammatory bowel diseases including Crohn's disease and ulcerative colitis.

Indexed as

AnimalsAnti-Ulcer AgentsCrohn DiseaseDisease Models, AnimalEndoscopy, GastrointestinalGastric MucosaHumansInflammation MediatorsIntestinal MucosaNeutrophilsPeptic UlcerProstaglandinsRecurrenceTreatment OutcomeWound HealingAnti-Ulcer AgentsInflammation MediatorsProstaglandinsCytokinesGrowth factorsPeptic ulcer diseaseProstaglandinQuality of ulcer healingRecurrence

Identifiers

PMID23002355
PMCPMC3447265
OpenAlexW1963959989

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.